Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narimane Nekkab

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Plos Computational Biology|February 26, 2026
Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling studyLydia Braunack-Mayer, Josephine Malinga, Narimane Nekkab, et al.
Plos Medicine|April 23, 2021
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling studyNarimane Nekkab, Raquel Lana, Marcus Lacerda, et al.
Malaria Journal|January 13, 2025
Therapeutic development to accelerate malaria control through intentional intervention layeringLydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, et al.
Malaria Journal|February 13, 2021
The top 1%: quantifying the unequal distribution of malaria in BrazilRaquel Lana, Narimane Nekkab, Andre M Siqueira, et al.
The Lancet. Global Health|February 16, 2024
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling studyLydia Braunack-Mayer, Josephine Malinga, Thiery Masserey, et al.
Plos Medicine|January 9, 2024
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission modelDavid J Price, Narimane Nekkab, Wuelton M Monteiro, et al.
PLOS Global Public Health|August 4, 2025
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burdenJosephine Malinga, Lydia Braunack-Mayer, Thiery Masserey, et al.
Plos Neglected Tropical Diseases|May 9, 2022
Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivaxJason Rosado, Gabriel Carrasco-Escobar, Oscar Nolasco, et al.
BMC Infectious Diseases|January 12, 2021
Monitoring sick leave data for early detection of influenza outbreaksTom Duchemin, Jonathan Bastard, Pearl Anne Ante-Testard, et al.
The Lancet. Microbe|February 1, 2021
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning studyJason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Plos Computational Biology|February 26, 2026
Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling studyLydia Braunack-Mayer, Josephine Malinga, Narimane Nekkab, et al.
Plos Medicine|April 23, 2021
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling studyNarimane Nekkab, Raquel Lana, Marcus Lacerda, et al.
Malaria Journal|January 13, 2025
Therapeutic development to accelerate malaria control through intentional intervention layeringLydia Braunack-Mayer, Narimane Nekkab, Josephine Malinga, et al.
Malaria Journal|February 13, 2021
The top 1%: quantifying the unequal distribution of malaria in BrazilRaquel Lana, Narimane Nekkab, Andre M Siqueira, et al.
The Lancet. Global Health|February 16, 2024
Design and selection of drug properties to increase the public health impact of next-generation seasonal malaria chemoprevention: a modelling studyLydia Braunack-Mayer, Josephine Malinga, Thiery Masserey, et al.
Plos Medicine|January 9, 2024
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission modelDavid J Price, Narimane Nekkab, Wuelton M Monteiro, et al.
PLOS Global Public Health|August 4, 2025
Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burdenJosephine Malinga, Lydia Braunack-Mayer, Thiery Masserey, et al.
Plos Neglected Tropical Diseases|May 9, 2022
Malaria transmission structure in the Peruvian Amazon through antibody signatures to Plasmodium vivaxJason Rosado, Gabriel Carrasco-Escobar, Oscar Nolasco, et al.
BMC Infectious Diseases|January 12, 2021
Monitoring sick leave data for early detection of influenza outbreaksTom Duchemin, Jonathan Bastard, Pearl Anne Ante-Testard, et al.
The Lancet. Microbe|February 1, 2021
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning studyJason Rosado, Stéphane Pelleau, Charlotte Cockram, et al.
Pageof 3